Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2004
03/31/2004EP1401835A1 Carboline derivatives as pde-5 inhibitors
03/31/2004EP1401834A1 New derivatives of oxazolidinones as antibacterial agents
03/31/2004EP1401831A1 Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
03/31/2004EP1401830A2 Quinazolinediones as antibacterial agents
03/31/2004EP1401829A1 Novel heterocyclic antibacterial compounds
03/31/2004EP1401825A2 Thiophene derivatives as antiviral agents for flavivirus infection
03/31/2004EP1401449A1 Tetracyclic compounds as pde5-inhibitors
03/31/2004EP1401440A1 Methods of use of fluoroquinolone compounds against bacteria
03/31/2004EP1401437A1 Immune response modifiers for the treatment of periodontal disease
03/31/2004EP1401427A2 Non-peptide gnrh agents, pharmaceutical compositions and methods for their uses, and processes for preparing them
03/31/2004EP1233944B1 Coupling condensation synthesis of heterocycles
03/31/2004EP1102766B1 Triazolopyridines for the treatment of thrombosis disorders
03/31/2004EP1037865A4 Synthesis of cc-1065/duocarmycin analogs
03/31/2004CN1486315A Dehalogeno compounds
03/31/2004CN1486314A Aminotriazolopyridiine derivatives as adenosine receptor ligands
03/31/2004CN1486312A Pyrazole compounds useful as protein kinase inhibitors
03/31/2004CN1486311A Pyrazole compounds useful as protein kinase inhibitors
03/31/2004CN1486310A Pyrazole compounds useful as protein kinase inhibitors
03/31/2004CN1486309A Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents)
03/31/2004CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
03/30/2004US6713493 Of neurological diseases involving attack of the pyramidal pathway such as: amyotrophic lateral sclerosis, progressive spinal muscular atrophy, infantile muscular atrophy, primary lateral sclerosis and cerebrovascular accident
03/30/2004US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
03/30/2004US6713485 Antiproliferative agents; side effect reduction
03/30/2004US6713484 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
03/30/2004US6713475 Tricyclic benzodiazepines (cyclic oligopeptides), useful for treatment of hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal failure, stroke or thrombosis
03/30/2004US6713471 Such as tert-butyl-1-methyl-6,7,9,12-tetrahydro-5h-pyrido-(4,3-b)(1,4) thiazepino(2,3,4-hi)indole-11(10h)-carboxylate; serotonin agonists and antagonists; central nervous system disorders
03/30/2004CA2291222C Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
03/30/2004CA2112981C Process for the preparation of optical isomers of a amino-2 napththyridine derivative
03/30/2004CA2079706C Inhibitor of atherosclerotic intimal thickening
03/25/2004WO2004024939A2 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
03/25/2004WO2004024897A2 PHENYL-AZA-BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
03/25/2004WO2004024728A2 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
03/25/2004WO2004024727A2 Synthesis of indolizines
03/25/2004WO2004024724A1 A heterocycle- substituted fused-heterocycle compounds having bioactivity
03/25/2004WO2004024720A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
03/25/2004WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof
03/25/2004WO2004024699A1 Benzimidazolones and their use as cytokine inhibitors
03/25/2004WO2004024693A1 Heterocyclic compound having hiv integrase inhibitory activity
03/25/2004WO2004024078A2 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
03/25/2004WO2004024076A2 Novel compositions and methods for the treatment of immune related diseases
03/25/2004WO2004024074A2 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators
03/25/2004WO2004018466A3 A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives
03/25/2004WO2004013138A3 Imidazo`1,2-a!pyridines
03/25/2004WO2003090680A3 Novel phenyl derivatives as inducers of apoptosis
03/25/2004WO2003074523A3 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
03/25/2004WO2003051366A3 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
03/25/2004WO2003027081A3 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER
03/25/2004WO2003014121A9 Compounds, derivatives, compositions, preparation and uses
03/25/2004US20040059145 Heterodiamondoids
03/25/2004US20040059138 Dihydropyrancarboxamides and uses thereof
03/25/2004US20040059127 Process and intermediates for the preparation of imidazopyridines
03/25/2004US20040058963 Cardiovascular disorders; hypotensive agents; antiallergens; antihistamines; antiarthritic agents; skin disorders
03/25/2004US20040058960 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/25/2004US20040058948 Transcripase inhibitor; viricides
03/25/2004US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
03/25/2004US20040058939 Derivatives of variolin b
03/25/2004US20040058938 Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
03/25/2004US20040058937 Heterocyclic mutilin esters and their use as antibacterials
03/25/2004US20040058934 Heterocyclic compounds
03/25/2004US20040058927 Tackykinin antagonist
03/25/2004US20040058915 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists
03/25/2004US20040058907 Compounds useful in the treatment of inflammatory diseases
03/25/2004US20040058905 FKBP inhibitors
03/25/2004US20040058900 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
03/25/2004US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
03/25/2004US20040058818 System for increasing the production of camptothecin from plants
03/25/2004US20040058091 Anisotropic films based on 1,8-naphthoylene-1',2'-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making
03/25/2004CA2498495A1 Phenyl-aza-benzimidazole compounds for modulating ige and inhibiting cellular proliferation
03/25/2004CA2498272A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
03/25/2004CA2498237A1 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators
03/25/2004CA2498111A1 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
03/25/2004CA2497661A1 Compositions and methods for the diagnosis of immune related diseases using pro71061
03/25/2004CA2497550A1 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
03/25/2004CA2496764A1 Synthesis of indolizines
03/25/2004CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
03/24/2004EP1400519A1 Respiratory syncytial virus replication inhibitors
03/24/2004EP1400241A1 Fused cyclic compounds and medicinal use thereof
03/24/2004EP1399455A2 Novel tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
03/24/2004EP1399445A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
03/24/2004EP1399444A2 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
03/24/2004EP1399443A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
03/24/2004EP1399442A1 Cak inhibitors and uses thereof
03/24/2004EP1399441A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists
03/24/2004EP1399436A2 Oxytocin agonists
03/24/2004EP1399432A1 Spiropiperidine compounds as ligands for orl-1 receptor
03/24/2004EP1399155A2 Small molecules useful in the treatment of inflammatory disease
03/24/2004EP1399154A1 3-fluoro-pyrrolidines as antidiabetic agents
03/24/2004EP1311509B1 Process for the preparation of imidazopyridines
03/24/2004EP0986560B1 Pyrrolo 2,1,5-cd]indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
03/24/2004CN1484679A Acid pigment dispersamts and pigment preparations
03/24/2004CN1484644A Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same
03/24/2004CN1484640A Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists
03/24/2004CN1142933C Heterocycilc compounds for inhibition of gastric acid secretion, processes for their prepn. and pharmaceutical composition thereof
03/24/2004CN1142912C Amide derivs, useful as inhibitors for production of cytokines
03/23/2004US6710204 N-oxyl compound contained in an easily polymerizable material can be sufficiently decreased and loss of easily polymerizable material (acrylic or methacrylic acids or their esters) is little
03/23/2004US6710064 Hydantoin compounds useful as anti-inflammatory agents
03/23/2004US6710055 Indole and benzimidazole antithrombotic compounds, such as 1-methyl-2-(n-amidinophenyl)-aminomethyl)-5-(n-(hydroxycarbo quinoline-8-sulfonylamino)-indole
03/23/2004US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
03/23/2004US6710047 Phthalazines with angiogenesis inhibiting activity
03/23/2004US6710042 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them